Case Report: Breast metastasis from biliary tract cancer: a rare case and literature review.

Yujun Tong, Yuzhu Ji, Zhen Zhang, Xiaohong Zhang, Zhuowei Tang

Abstract readCase Reports

In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yujun Tong *Department of Breast Center, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.

Yuzhu Ji *Department of Pathology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.

Zhen ZhangDepartment of Breast Center, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.

Xiaohong ZhangDepartment of Breast Center, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.

Zhuowei TangDepartment of Breast Center, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast metastasis from biliary tract cancer (BTC) is an extremely rare clinical occurrence. We report the case of a 59-year-old woman who was incidentally found to have a hepatic mass, leading to a comprehensive workup prompted by progressive chest discomfort. Clinical examination revealed a firm left breast with nipple retraction and a palpable axillary mass. Imaging confirmed a non-mass enhancement lesion in the left breast along with extensive metastases to the liver, lungs, bone, and mediastinal lymph nodes. Core needle biopsies of the breast and abdominal wall lesion showed morphologically similar adenocarcinoma. Immunohistochemistry (IHC) was instrumental in the diagnosis, demonstrating positivity for CK19 and IMP3, focal positivity for CDX2, and a high Ki-67 index (80%), while key breast markers (GATA3, ER, PR, and HER2) were all negative. This immunoprofile strongly supported a biliary origin. The patient was diagnosed with advanced BTC with multiple metastases, including to the breast. She received supportive care and was referred for systemic therapy evaluation. This case highlights that BTC breast metastasis can mimic primary breast carcinoma, underscoring the critical role of pathology and IHC in achieving an accurate diagnosis, which is essential for guiding appropriate, individualized treatment and avoiding unnecessary surgery.

Indexed as

biliary tract cancerbreast metastasiscase reportdiagnosisepithelial-mesenchymal transition (EMT)immunohistochemistrymucinous adenocarcinoma

Identifiers

PMID41836267

DOI10.3389/fonc.2026.1705918

PMCPMC12979169

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.